Covid-19 roundup: The FDA gives Mod­er­na’s Covid-19 team a reg­u­la­to­ry em­brace to go along with the cheers and jeers; BioN­Tech ex­pects first coro­n­avirus da­ta in a mat­ter of weeks

The FDA of­fered a lit­tle ex­tra pub­lic as­sur­ance to­day that Mod­er­na could ex­pect an open door every time ex­ecs come knock­ing as they piece to­geth­er their Phase III pro­to­cols for an ul­tra-quick tri­al launch. The agency has hand­ed fast track sta­tus to Mod­er­na for its Covid-19 mR­NA vac­cine — though with every­one from the pres­i­dent on down clam­or­ing for a de­fin­i­tive end to the pan­dem­ic, that may have been a bit un­nec­es­sary.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER